Imodium Diarrea E Meteorismo (Dimeticone, Loperamide Hydrochloride)

Loperamide acts on µ‑opioid receptors in the gut wall, slowing intestinal motility and allowing more water to be absorbed, which firms up stool. Dimeticone, on the other hand, reduces the surface tension of gas bubbles, causing them to coalesce and be expelled more easily, thereby relieving bloating.

The appropriate dose is determined by a qualified healthcare professional based on the patient’s age, weight, severity of symptoms, and clinical condition. Prescribers tailor the regimen to achieve optimal symptom control while minimizing the risk of adverse effects.

Safety data are limited. The product should only be used during pregnancy or lactation if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss alternatives when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Unlike single‑component antidiarrheals, this product combines loperamide with dimeticone, offering both motility reduction and gas‑relief in one formulation. This dual action can be advantageous for patients who experience both diarrhea and bloating, whereas traditional loperamide‑only products address only stool frequency.

Store the tablets at temperatures below 25 °C in a dry place. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging is tightly closed to maintain product stability.

The medication is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the prescriber’s instructions regarding timing relative to meals to achieve the best therapeutic effect.

Serious risks include severe constipation leading to intestinal blockage, toxic megacolon, and rare allergic reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience abdominal pain, inability to pass stool, or signs of a severe skin reaction.

The product should be avoided in individuals with known hypersensitivity to dimeticone or loperamide, in children younger than two years, and in patients with active bacterial dysentery, pseudomembranous colitis, or unexplained acute abdominal pain until a diagnosis is confirmed.